Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.

Later on in the day, confirmation finally came in – Zoryve had been approved as a new, once-daily treatment for mild to moderate atopic dermatitis in adults and children six years of age and ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

This accomplishment underscores the drug's effectiveness across ... for increased competition in atopic dermatitis treatments and potentially introduce a new therapeutic option to the market." ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Jonathan Wolleben, an analyst from JMP Securities, has initiated a new Buy rating on Astria Therapeutics (ATXS).Invest with Confidence: Follow ...

The most reported signs were erythema, desquamation, dryness, and oozing affecting the face, neck, and upper extremities.

According to a new study, Fluticasone lotion may be safely used as short-term treatment of eczema - or more precisely, atopic dermatitis - in children 3 months of age or older. Red, cracked ...

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...